Revisiting checkpoint blockade - Nature Biotechnology

United States News News

Revisiting checkpoint blockade - Nature Biotechnology
United States Latest News,United States Headlines
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 63%

Editorial: Revisiting checkpoint blockade

of which set the field alight in 2020 — does “not appear to be therapeutically relevant” in small-cell lung cancer.

Given the high attrition of ICI candidates, there was a buzz at ASCO around biomarkers that can optimize patient selection. A particularly impressive example is the use of high DNA microsatellite instability in aof an anti-PD-1 mAb used as a neoadjuvant in stage 2–3 rectal cancer; although the trial involved only 12 patients, every MSI-high patient responded, remaining in remission after up to two years.

Although MSI-high status is uncommon in cancers, immune biomarkers promise wider applicability. One ASCO presentation describing a retrospective analysis of patients undergoing PD-1/PD-L1 immunotherapy in lung cancer reported that low scores in an panel all relapsed within 45 days, whereas only a third of patients with high scores relapsed in three years. Similarly, an algorithm for classifyingwas reported to be effective at predicting anti-PD-1 mAb responders in a phase 2 trial of solid tumors . Combining this panel with measurements of circulating tumor DNA further improved predictive power. Several other markers —

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NatureBiotech /  🏆 231. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs - Nature BiotechnologyA multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs - Nature BiotechnologyA multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Read more »

Generation of a live attenuated influenza A vaccine by proteolysis targeting - Nature BiotechnologyGeneration of a live attenuated influenza A vaccine by proteolysis targeting - Nature BiotechnologyInfluenza virus is attenuated for vaccine production using PROTAC degradation technology.
Read more »

Synthetic memory circuits for stable cell reprogramming in plants - Nature BiotechnologySynthetic memory circuits for stable cell reprogramming in plants - Nature BiotechnologyTranscriptional activity in plants is controlled with a programmable gene circuit.
Read more »

Deep tissue multi-photon imaging using adaptive optics with direct focus sensing and shaping - Nature BiotechnologyDeep tissue multi-photon imaging using adaptive optics with direct focus sensing and shaping - Nature BiotechnologyALPHA-FSS enables high-resolution imaging deep in the mouse brain.
Read more »

Physicists Stunned by Nature in the Wrong Direction: Magnetic Spins That “Freeze” When HeatedPhysicists Stunned by Nature in the Wrong Direction: Magnetic Spins That “Freeze” When HeatedPhysicists observed a very strange new type of behavior in a magnetic material when it’s heated up. When the temperature rises, the magnetic spins ‘freeze’ into a static pattern, a phenomenon that normally occurs when the temperature decreases. Their findings were published in Nature Physics today,
Read more »

For America's birthday, Mother Nature gives California a gift: cool temperatures.For America's birthday, Mother Nature gives California a gift: cool temperatures.In a Fourth of July rarity, the weather in Southern California is nearly perfect as temperatures soar across the country.
Read more »



Render Time: 2025-02-23 03:38:23